I agree that this site is using cookies. You can find further informations here.
X
Slomovitz, Brian
142  results:
Search for persons X
?
1

Top advances of the year: Uterine cancer:

Erickson, Britt K. ; Slomovitz, Brian ; Powell, Matthew.
Cancer.  130 (2024)  14 - p. 2409-2412 , 2024
Link: https://doi.org/10.1002/..
 
?
2

ENGOT-EN20/GOG-3083/XPORT-EC-042 – A phase III, randomized,..:

Vergote, Ignace ; Perez Fidalgo, Alejandro ; Valabrega, Giorgio...
International Journal of Gynecologic Cancer.  , 2024
Link: https://doi.org/10.1136/..
 
?
3

Mismatch repair deficiency, next-generation sequencing-base..:

Hill, Breana L ; Graf, Ryon P ; Shah, Kunal...
International Journal of Gynecologic Cancer.  33 (2023)  4 - p. 504-513 , 2023
Link: https://doi.org/10.1136/..
 
?
4

Randomized phase II trial of farletuzumab plus chemotherapy..:

Herzog, Thomas J. ; Pignata, Sandro ; Ghamande, Sharad A....
Gynecologic Oncology.  170 (2023)  - p. 300-308 , 2023
Link: https://doi.org/10.1016/..
 
?
5

Characterization and Management of Adverse Reactions in Pat..:

Colombo, Nicoletta ; Lorusso, Domenica ; Monk, Bradley J...
The Oncologist.  29 (2023)  1 - p. 25-35 , 2023
Link: https://doi.org/10.1093/..
 
?
6

Evolving treatment paradigms in metastatic or recurrent low..:

Mahdi, Haider ; Ray-Coquard, Isabelle ; Lorusso, Domenica...
International Journal of Gynecologic Cancer.  33 (2023)  11 - p. 1675-1681 , 2023
Link: https://doi.org/10.1136/..
 
?
7

The promise of combining CDK4/6 inhibition with hormonal th..:

Ray-Coquard, Isabelle ; Monk, Bradley J ; Lorusso, Domenica...
International Journal of Gynecologic Cancer.  33 (2023)  12 - p. 1943-1949 , 2023
Link: https://doi.org/10.1136/..
 
?
8

ENGOT-EN20/GOG-3083/XPORT-EC-042 A phase 3, randomized, pla..:

Makker, Vicky ; Vergote, Ignace ; Mirza, Mansoor...
Gynecologic Oncology.  176 (2023)  - p. S156 , 2023
Link: https://doi.org/10.1016/..
 
?
9

AFT-50 EndoMAP: A phase IB/II multicohort study of targeted..:

Cantillo, Evelyn ; Slomovitz, Brian
Gynecologic Oncology.  176 (2023)  - p. S187 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Dostarlimab in combination with chemotherapy for the treatm..:

Mirza, Mansoor ; Chase, Dana ; Slomovitz, Brian...
Gynecologic Oncology.  176 (2023)  - p. S43-S44 , 2023
Link: https://doi.org/10.1016/..
 
?
11

GOG 3026 A phase II trial of letrozole + ribociclib in wome..:

Slomovitz, Brian ; Deng, Wei ; Killion, Josh...
Gynecologic Oncology.  176 (2023)  - p. S2 , 2023
Link: https://doi.org/10.1016/..
 
?
12

Trametinib versus standard of care in patients with recurre..:

Gershenson, David M ; Miller, Austin ; Brady, William E...
The Lancet.  399 (2022)  10324 - p. 541-553 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Factors contributing to delays in initiation of front-line ..:

Roy, Molly ; Finch, Lindsey ; Kwon, Deukwoo...
International Journal of Gynecologic Cancer.  32 (2022)  11 - p. 1387-1394 , 2022
Link: https://doi.org/10.1136/..
 
?
14

Practice changing cervical cancer clinical trials:

Pothuri, Bhavana ; Eskander, Ramez N. ; Randall, Leslie M....
Gynecologic Oncology.  165 (2022)  3 - p. 410-412 , 2022
Link: https://doi.org/10.1016/..
 
?
15

ENGOT-en11/GOG-3053/KEYNOTE-B21: A phase 3 study of pembrol..:

Slomovitz, Brian ; Mirza, Mansoor ; Lortholary, Alain...
Gynecologic Oncology.  166 (2022)  - p. S278 , 2022
Link: https://doi.org/10.1016/..
 
1-15